virus clearance – Page 4 – Communicable Diseases Research

Immune response variables and viral mutations impact on COVID-19 reinfection and relapse

Review

Published on 2021-09-082022-10-04
Journal: International immunopharmacology [Category] MERS, SARS, 변종, 유전자 메커니즘, 진단,

[키워드] activated Adaptive immune response Affect antibody antiviral antibodies Characteristics Comorbidities coronavirus COVID-19 COVID-19 pathogenesis Cytokines disease high risk Human immune parameter immune response individuals Innate investigated Lymphocytes mechanism media memory B cells multiple mutation Mutation Neutralizing antibodies precluded PROTECT protective antibody response rates of infection Reinfection repeated response variable responsible SARS-CoV-2 susceptibility trajectory Transmissibility underlying diseases variables viral mutation virus virus clearance virus infection Virus life cycle virus RNA virus spread
[DOI] 10.1016/j.intimp.2021.108108 PMC 바로가기 [Article Type] Review

Differential Effects of Prostaglandin D 2 Signaling on Macrophages and Microglia in Murine Coronavirus Encephalomyelitis

Research Article

Published on 2021-09-072022-10-29
Journal: mBio [Category] Coronavirus,

SARS-CoV-2 Antibodies and Associated Factors at Different Hospitalization Time Points in 192 COVID-19 Cases

192개의 COVID-19 사례에서 다양한 입원 시점의 SARS-CoV-2 항체 및 관련 요인

Article

Published on 2021-09-012022-09-11
Journal: The journal of applied laboratory medicine [Category] SARS, 진단, 치료기술,

[키워드] age analyzed anti-SARS-CoV-2 IgG anti-SARS-CoV-2 IgM antibody chemiluminescence immunoassay Cohort confirmed case confirmed cases correlated correlation Correlation analysis COVID-19 COVID-19 case COVID-19 diagnosis disease severity early phase enrolled expression expression level Factor female patient Female patients Gender groups Guangzhou Guangzhou, China healthy hospital IgG IgG antibodies IgM IgM and IgG IgM seroconversion indicated Infection kinetic Kinetics male occurred Patient patients patients with COVID-19 Point positively correlated Replication Retrospective analysis sampling SARS-CoV-2 SARS-CoV-2 antibodies SARS-CoV-2 antibody Seroconversion severity of COVID-19 suspected patient Symptoms time Univariate analysis virus virus clearance was collected was related while with COVID-19
[DOI] 10.1093/jalm/jfab003 PMC 바로가기 [Article Type] Article

Interferon-alpha position in combating with COVID-19: A systematic review

COVID-19와의 싸움에서 인터페론-알파의 위치: 체계적인 검토

Review

Published on 2021-09-012022-09-11
Journal: Journal of medical virology [Category] 임상, 치료제,

Comparative therapeutic efficacy of interferon alfa-2b and combination lopinavir/ritonavir plus interferon alfa-2b against SARS-CoV-2

SARS-COV-2에 대한 인터페론 ALFA-2B 및 조합 Lopinavir/Ritonavir Plus 인터페론 ALFA-2B의 비교 치료 효능

Research Article

Published on 2021-08-302022-09-10
Journal: BMC Infectious Diseases [Category] SARS, 치료제,

[키워드] Adult patients adverse event adverse events antiviral drug antiviral drugs assigned association benefit clearance Clinical characteristics clinical monitoring Combination Comparative confidence interval coronavirus disease Coronavirus disease 2019 Coronavirus disease 2019 (COVID-19) COVID-19 Cox proportional hazard Cox proportional hazards regression disease Efficacy and safety evaluate faster group incidence individual Infection interferon interferon alfa-2b Lopinavir Lopinavir/ritonavir Nasopharyngeal swab no significant difference no significant differences not significantly different outbreak outcome oxygen oxygen support Patient patients hospitalized patients with SARS-CoV-2 PCR Pneumonia primary endpoint primary endpoints public health required Result retrospective cohort study Ritonavir SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 RNA severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) significant differences standard care group standard supportive care Symptom therapeutic efficacy therapy three group three groups Treatment treatment guideline treatment guidelines triggered virus virus clearance were assessed with COVID-19
[DOI] 10.1186/s12879-021-06595-6 PMC 바로가기 [Article Type] Research Article

Modeling Within-Host Dynamics of SARS-CoV-2 Infection: A Case Study in Ferrets

Article

Published on 2021-08-182022-10-28
Journal: Viruses [Category] COVID-19, MERS, SARS,

Risk factors for prolonged virus shedding of respiratory tract and fecal in adults with severe acute respiratory syndrome coronavirus‐2 infection

중증급성호흡기증후군 코로나바이러스-2 감염 성인의 호흡기 및 대변의 장기간 바이러스 배출 위험인자

Research Article

Published on 2021-08-132022-09-10
Journal: Journal of Clinical Laboratory Analysis [Category] MERS, SARS, 치료제,

[키워드] 95% CI acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 Admission age and gender Analysis Antiviral Antiviral treatment BMI carried CD4+ T cell Chloroquine Chloroquine phosphate Combination coronavirus COVID‐19 COVID‐19 patient COVID‐19 determine during treatment effective enrolled Factor Factors fecal immunomodulatory independent risk factor independent risk factors Infection initial longitudinal study Lopinavir Lopinavir/ritonavir mechanism multivariable logistic regression Multivariable logistic regression analysis multivariate logistic regression multivariate logistic regression analysis NK cell NK cells obesity on admission pattern phosphate positive potential risk prolonged viral shedding rectal swab regimen respiratory respiratory tract Result retrospective risk factor Ritonavir RNA SARS‐CoV‐2 SARS‐CoV‐2 severe acute respiratory syndrome Coronavirus significantly Stool suggested T cell Treatment Viral viral shedding virus virus clearance
[DOI] 10.1002/jcla.23923 PMC 바로가기 [Article Type] Research Article

Case Report: Convalescent Plasma Therapy Induced Anti-SARS-CoV-2 T Cell Expansion, NK Cell Maturation and Virus Clearance in a B Cell Deficient Patient After CD19 CAR T Cell Therapy

증례 보고서: CD19 CAR T 세포 치료 후 B 세포 결핍 환자의 회복기 혈장 치료 유도 항-SARS-CoV-2 T 세포 확장, NK 세포 성숙 및 바이러스 제거

Case Reports

Published on 2021-08-122022-09-12
Journal: Frontiers in Immunology [Category] MERS, SARS, 진단,

Myasthenic crisis following SARS-CoV-2 infection and delayed virus clearance in a patient treated with rituximab: clinical course and 6-month follow-up

SARS-CoV-2 감염 후 근무력증 위기 및 리툭시맙 치료 환자의 바이러스 제거 지연: 임상 경과 및 6개월 추적관찰

Article

Published on 2021-08-012022-09-12
Journal: Journal of Neurology [Category] MERS, SARS, 진단,

[키워드] Clinical course Follow-up Patient SARS-COV-2 infection treated virus clearance
[DOI] 10.1007/s00415-020-10310-x PMC 바로가기 [Article Type] Article

A Kidney Transplant Patient Who Died of COVID-19-associated Severe Acute Respiratory Distress Syndrome

COVID-19 관련 중증 급성 호흡곤란 증후군으로 사망한 신장 이식 환자

Case Reports

Published on 2021-07-152022-09-11
Journal: Internal medicine (Tokyo, Japan) [Category] SARS, 치료기술,